Plexin D1 negatively regulates zebrafish lymphatic development

Author:

Britto Denver D.1,He Jia2,Misa June P.1ORCID,Chen Wenxuan1,Kakadia Purvi M.13,Grimm Lin456ORCID,Herbert Caitlin D.1,Crosier Kathryn E.1,Crosier Philip S.1,Bohlander Stefan K.13,Hogan Benjamin M.456,Hall Christopher J.1,Torres-Vázquez Jesús2,Astin Jonathan W.1ORCID

Affiliation:

1. School of Medical Sciences, University of Auckland 1 Department of Molecular Medicine and Pathology , , Auckland 1023 , New Zealand

2. Skirball Institute of Biomolecular Medicine, New York University Grossman School of Medicine 2 , New York, NY 10016 , USA

3. The University of Auckland 3 Leukaemia and Blood Cancer Research Unit, Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences , , Auckland 1023 , New Zealand

4. Peter MacCallum Cancer Centre 4 Organogenesis and Cancer Program , , Melbourne 3000 , Australia

5. University of Melbourne 5 Sir Peter MacCallum Department of Oncology , , Melbourne 3010 , Australia

6. University of Melbourne 6 Department of Anatomy and Physiology , , Melbourne 3010 , Australia

Abstract

ABSTRACT Lymphangiogenesis is a dynamic process that involves the directed migration of lymphatic endothelial cells (LECs) to form lymphatic vessels. The molecular mechanisms that underpin lymphatic vessel patterning are not fully elucidated and, to date, no global regulator of lymphatic vessel guidance is known. In this study, we identify the transmembrane cell signalling receptor Plexin D1 (Plxnd1) as a negative regulator of both lymphatic vessel guidance and lymphangiogenesis in zebrafish. plxnd1 is expressed in developing lymphatics and is required for the guidance of both the trunk and facial lymphatic networks. Loss of plxnd1 is associated with misguided intersegmental lymphatic vessel growth and aberrant facial lymphatic branches. Lymphatic guidance in the trunk is mediated, at least in part, by the Plxnd1 ligands, Semaphorin 3AA and Semaphorin 3C. Finally, we show that Plxnd1 normally antagonises Vegfr/Erk signalling to ensure the correct number of facial LECs and that loss of plxnd1 results in facial lymphatic hyperplasia. As a global negative regulator of lymphatic vessel development, the Sema/Plxnd1 signalling pathway is a potential therapeutic target for treating diseases associated with dysregulated lymphatic growth.

Funder

Health Research Council of New Zealand

Royal Society of New Zealand

Marsden Fund

Family of Marijana Kumerich

Leukaemia and Blood Cancer New Zealand

National Institutes of Health

Publisher

The Company of Biologists

Subject

Developmental Biology,Molecular Biology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3